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Abstract 
Trigonella foenum-graecum (Fenugreek) leaves exhibit antidiabetic and antioxidant 
properties. The present study was designed to elucidate the insulin stimulatory effect 
on supplementation of fenugreek leaves in streptozotocin-induced diabetes in rats. 
Supplementation of fenugreek leaves mixed with diet at doses of 0.5g and 1.0g/kg of 
body weight twice daily to diabetic rats for a period of 45days resulted in change in 
bodyweight, increase in weight of pancreas, enhances the insulin levels and a significant 
decrease in fasting blood glucose levels. Histopathological observations showed 
marked changes of the pancreas in treatment with the fenugreek leaves improved the 
functional state of the pancreatic β-cells and partially retained the damage caused by 
streptozotocin to the pancreatic islets. These findings of our study clearly indicate the 
insulin stimulatory effect of fenugreek leaves. The effect observed with the fenugreek 
leaves was better than that of glibenclamide (600 µg/kg bodyweight).  
 
1. Introduction 
Diabetes mellitus is a syndrome, initially 
characterized by a loss of glucose homeostasis 
resulting from defects in insulin secretion, insulin 
action both resulting in impaired metabolism of 
glucose and other energy-yielding fuels such as 
lipids and protein(WHO, 1985). 
The mechanism of most of the herbals used to 
treat diabetes has not been defined (Bailey  1989). It 
has been attributed that the antihyperglycemic 
effect of these plants is due to their ability to 
restore the function of pancreatic tissues by causing 
an increase in insulin output or inhibit the intestinal 
absorption of glucose or to the facilitation of 
metabolites in insulin dependent processes. Hence 
treatment with herbal drugs has an effect on 
protecting β cells and smoothing out fluctuation in 
glucose levels (Jia et al. 2003 and Elder  2004). 
Most of the plants have been found to contain 
substances like glycosides, alkaloids, terpenoids, 
flavonoids etc. that are frequently implicated as 
having antidiabetic effects. But little is known on 
the specific modes of action of these plant drugs or 
herbal formulation used for treating diabetes (Loew 
and Kaszkin  2002). Plant drugs (Halberstein  2005) 
and herbal formulation (Mitra et al.  1996) are 
frequently considered to be less toxic and more free 
from side effects than synthetic one.  
Trigonella foenum-graecum l. (Leguminoseae) 
is an erect, strongly scented annual herb that is 
extensively cultivated as a food crop in India, the 
Mediterranean region, North Africa, and Yemen, 
Indigenous People use both leaves and seeds of this 
plant to treat diabetes mellitus, Fenugreek leaves 
are consumed widely in India as a green, leafy veg-
etable and are a rich source of calcium, iron, B-
carotene, and vitamin K (Sharma  1986). 
Previous studies have shown that the water 
extract of fenugreek leaves given both orally and 
intraperitoneally ex-hibits a hypoglycemic effect in 
normal and alloxan-treated diabetic rats (Al-Habori 
and Raman 1998) there are no available reports on 
the effect of supplementation with fenugreek leaves 
in experimental diabetes. Hence, we have planned 
to study whether supplementation with fenugreek 
leaves exerts stimulatory effect of insulin in 
streptozotocin (STZ) - induced diabetes. 
 
2. Materials and Methods 
Plant material  
Fenugreek leaves were purchased from the 
local market, and their botanical identity was 
confirmed by a botanist from the Department of 
Botany, Annamalai University. The leaves were 
cleaned, dried, and finely powdered. The powder 
was used for feeding the rats; it was mixed with the 
diet at a level of 0.5 g and 1 g/kg of body weight. 
 
Chemicals 
 Streptozotocin was purchased from Sigma 
chemical Co., St.Louis Mo. USA. All other 
chemicals and biochemicals used in our study were 
of high-grade quality.   
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Animals and Diet 
All the animal experiments carried out by us 
were approved by the ethics committee of 
Annamalai University, Tamil Nadu, India. Adult 
female albino rats of the Wistar strain weighing 
170-200g were obtained from the Central Animal 
House, Department of Experimental Medicine, 
Annamalai University, Rajah Muthiah Medical 
College & Hospital, Annamalai University and were 
used in the present study. They were housed in 
polypropylene cages (47×34× 20cm) lined with 
husk, renewed every 24h under a 12:12 h light dark 
cycle at around 22°C and had free access to tap 
water and food. 
The animals were fed with a standard pellet 
diet (Kamadhenu Agencies, Bangalore, India).The 
pellet diet consisted of 22.02% crude protein, 
4.25% crude oil, 3.02% crude fibre, 7.5% ash, 
1.38% sand silica, 0.8% calcium, 0.6%phosphorus, 
2.46% glucose, 1.8% vitamins and 56.17% 
carbohydrates. It provided a metabolisable energy 
of 3600kcal.  
 
Induction of diabetes in rats 
Diabetes was induced in rats by a single 
intraperitoneal injection of freshly prepared STZ 
(40mg/kg of body weight) in 0.1 M citrate buffer 
(pH 4.5) in a volume of 1 ml/kg (Fathy El-Fiky et 
al. 1996). Forty-eight hours after STZ injection. 
The blood glucose level of each rat was determined. 
Rats having a blood glucose range of 220-260 
mg/dl were considered diabetic and included in the 
study. 
 
Experimental design 
In our study, we used a total of 36 rats (six 
normal and 30 STZ – induced diabetic surviving). 
The rats were divided into six groups of six rats 
each: Group 1, normal untreated rats; Group 2, 
STZ-induced diabetic rats; Groups 3 and 4, STZ-
induced diabetic rats supplemented with fenugreek 
leaves (0.5 or 1 g/kg of body weight, respectively) 
daily in the diet for a period of 45 days (AnithaDevi 
et al. 2003); Group 5, STZ-induced diabetic rats 
given glibencamide (600 µg/kg of body weight) 
daily for 45 days (AnithaDevi et al. 2003); and 
Group 6, STZ-induced diabetic rats given insulin 
( 6 units/kg of body weight) daily intraperitoneally 
for 45 days (AnithaDevi et al. 2004).The food 
intake was measured daily throughout the 
experiment. 
 
Biochemical estimations   
 After the last treatment, the rats were fasted 
overnight and killed by cervical dislocation. Blood 
was collected in heparinized tubes and centrifuged 
at 5000 rpm for 10 min. Plasma was separated by 
aspiration, transferred into eppendorf tubes, and 
stored at-20°C for analysis. Blood glucose was 
estimated by the method of Sasaki et al. (1972). 
Plasma insulin assay was carried out by ELISA 
method using a Boehringer Mannheim Kit 
(Boehringer analyser Es 300), Mannheim, Germany.  
 
Histopathological study 
For histopathological study, two animals from 
each group were perfused with formalin (10%) and 
the tissues were separated and stored in 10% 
formalin. They were later dehydrated in graded 
alcohol, embedded in paraffin sectioned using a 
microtome, and stained with hemotoxylin and eosin 
(H&E).   
Pancreas was removed immediately and fixed 
for histology. The histological observation was 
made under light microscope. 
 
Statistical analysis 
All the grouped data were statistically evaluated 
and the obtained data were analyzed by one way 
ANOVA followed by Duncan’s Multiple Range 
Test (DMRT). P values<0.01 were considered as 
significant. 
 
3. Results 
Figure 1 shows the blood glucose levels in 
normal and experimental rats.  There was a 
significant increase in the blood glucose levels in 
streptozotcin diabetic rats as compared to normal 
rats. Supplementation of fenugreek leaves in 
diabetic rats decreased blood glucose. 
 
 
Figure 1. Effect of Fenugreek leaves on blood glucose in 
normal and STZ-diabetic rats. Each value is mean ± SD for 
6 rats in each group. Values not sharing a common 
superscript differ significantly at p< 0.01 (DMRT). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 shows the levels of plasma insulin in 
normal and streptozotocin diabetic rats. Treatment 
with fenugreek leaves (0.5or1gm/kg body weight) 
enhances the plasma insulin levels in diabetic rats. 
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Figure 2.  Effect of Fenugreek leaves on plasma insulin in 
normal and STZ-diabetic rats. Each value is mean ± SD for 
6 rats in each group. Values not sharing a common 
superscript differ significantly at p< 0.01 (DMRT). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 illustrates the change in bodyweight of 
STZ diabetic rats.  In diabetic rats we found lose of 
weight when compared to normal rats. 
Supplementation of fenugreek leaves (0.5or1gm/kg 
bodyweight) to STZ treated diabetic rats improved 
in weight gain. 
 
 
Figure 3.  Effect of Fenugreek leaves on change in body 
weight of normal and STZ –diabetic rats. Each value is 
mean ± SD for 6 rats in each group. Values not sharing a 
common superscript differ significantly at p< 0.01 (DMRT). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 shows the effect of supplementation 
of fenugreek leaves and change in weight of 
pancreas in diabetic rats. There was a significant 
change in weight of pancreas in STZ treated 
diabetic rats compared to normal. Treatment with 
fenugreek leaves at doses of (0.5 or1 gm/kg 
bodyweight) improved the weight gain of pancreas 
in diabetic rats.  
 
 
 
 
 
 
 
Figure 4. Effect of Fenugreek leaves on organ (pancreas) 
weight of normal and STZ-diabetic rats. Each value is mean 
± SD for 6 rats in each group. Values not sharing a 
common superscript differ significantly at p< 0.01 (DMRT). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 shows normal rats pancreas 
H&EXp100X normal acini with and cell 
 
Figure 5. Normal  pancreas – Normal acini with β cells. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 shows diabetic pancreas H&EX100X 
destroyed β cells of islets 
 
Figure 6. Diabetic pancreas – Destroyed β cells of islets 
were seen 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 shows Diabetic + fenugreek leaves 
(0.5gm/kg body wt.) treated rats pancreas 
H&EX100X partially regenerated and cells 
 
 
28 
Annida Balakrishnan and Venugopal. P.  Menon  
Figure 7. Fenugreek leaves (0.5 gm/kg) treated pancreas – 
partially regenerated β cells 
 
 
 
 
  
 
 
 
 
 
 
Figure 8 shows diabetic + fenugreek leaves (1 
gm/kg body wt.) treated rats pancreas H&EX100X 
regenerated and cells of islets 
 
Figure 8. Fenugreek leaves (1.0gm/kg) treated pancreas – 
Regenerated β cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 shows diabetic + Glibenclamide 
treated rat’s pancreas H&EX100X Regenerating & 
cell 
 
Figure 9. Glibenclamide (600 µg/kg) treated pancreas – 
Regenerating β cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 shows Diabetic + Insulin treated rat 
pancreas H&EX100X Well preserved & cells of 
islets 
 
 
 
Figure 10. Diabetic +insulin treated rat pancreas- Well 
preserved β cells of islets 
 
 
 
 
 
 
 
 
 
 
4. Discussion 
At present, the treatment of diabetes mainly 
involves a sustained reduction in hyperglycaemia by 
the use of biguanides, thiazolidinediones, 
sulphonylureas, Dphenylalanine derivatives, 
meglitinides and á-glucosidase inhibitors in addition 
to insulin. However, due to unwanted side effects 
the efficacies of these compounds are debatable 
and there is a demand for new compounds for the 
treatment of diabetes (Jackson and Bressler   1981; 
Thirunavukkarasu et al. 2003). Hence, plants have 
been suggested as a rich, as yet unexplored source 
of potentially useful antidiabetic drugs. However, 
only a few have been subjected to detailed scientific 
investigation due to a lack of mechanism-based 
available in vitro assays (Saxena and Vikram  2004). 
Fenugreek (Trigonella foenum graecum L., Leguminosae), 
as mentioned before is one of the oldest medicinal 
plants, its aqueous extracts of seeds and leaves of 
fenugreek have been shown to possess 
hypoglycaemic activity and are nontoxic (Abdel-
Barry 2000). 
Fenugreek (Trigonella foenum-graecum) (TFG) is a 
plant with traditional medicinal use in diabetes and 
its beneficial effects have been demonstrated in 
diabetic animals and both insulin-dependent and 
non- insulin-dependent diabetic subjects (Al-
Habori et al. 2001). 
Hypoglycemic and antihyperglycemic effects of 
fenugreek seeds (Alarcon-Aguilara et al. 1998) and 
aqueous leaf extracts (Abdel-Barry et al. 1997) have 
previously been reported in experimentally induced 
diabetic rats. Since, there is no strong scientific 
evidence for therapeutic and pharmacological 
properties of TFG. We have studied the insulin 
stimulatory effect of fenugreek leaves on 
streptozotocin induced diabetes rats. 
Streptozotocin which is a naturally occurring 
chemical discovered in strain of soil microbe is 
particularly toxic to the insulin producing beta cells 
of the pancreas in mammals. It is used in medicine 
for treating certain cancers of the islets of 
Langerhans and used in medical research to 
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produce permanent animal model of Type I 
diabetes (Brentjens and Saltz 2001). 
Streptozotocin-induced diabetes provides a 
condition of insulinopenia and has been described 
as a useful experimental model to evaluate the 
activity of hypoglycemic agents (Bailey and Flatt  
1986). The use of a lower dose of STZ produced an 
incomplete destruction of pancreatic β – cells even 
though rats became permanently diabetic (Aybar et 
al. 2001). We have observed decreased blood 
glucose levels in STZ - diabetic rats treated with 
fenugreek leaves. Since the supplementation of 
fenugreek leaves with the food reduced the blood 
glucose potently in streptozotocin-diabetc rats it 
may be assumed that the diabetic state is not severe. 
Thus, the fenugreek leaves supplemented may act 
by a direct stimulation of insulin secretion in 
remaining β-cells. This effect could be attributed to 
due to the presence of flavonoids, xanthophylls, 
metals chelating agents (chromium, manganese and 
magnesium) (Fatima et al. 2004) and glucoside in 
fenugreek leaves, that stimulate insulin secretion.  
Loss of body weight and the weight of 
pancreas were reduced in the diabetic rats. The 
decrease in body weight could be due to 
dehydration and the catabolism of fats and proteins 
seen during diabetes mellitus (Hakim et al. 1997). 
Supplementation of fenugreek leaves improved 
body weight (Anitha Devi et al. 2003) and organ 
(pancreas) weight.  This is due to the effect of 
fenugreek leaves supplementation and its ability to 
reduce hyperglycaemia (Anitha Devi et al. 2003) 
The glucose lowering activity observed in the 
diabetic animal may be due to the stimulation of β 
cells of pancreatic islets, also may be mediated 
through stimulation of insulin release resembling 
the oral hypoglycemic sulfonyl ureas or peripheral 
glucose utilization (Ivorra et al. 1988). This may be 
due to the presence of some hypoglycemic agents 
present in the fenugreek leaf powder, which were 
similar to insulin or oral hypoglycemic drugs. 
Insulin levels were found to be increased 
significantly upon treatment with fenugreek leaves 
to the diabetic rats. An increase in the insulin levels 
reflects the regeneration of β – cells from the 
damaged pancreas by supplementation of fenugreek 
leaves. Gomes et al. (1995) have stated that after 
low dose of STZ-treatment, there should be many 
surviving β – cells and cell regeneration is also 
possible. Das et al. (1996) have shown that the 
damage caused by STZ (45 mg/kg) to the pancreas 
of Sprague Dawley rats was reversed by the A. 
marmelos leaf extract treatment. These finings are 
in line with our results, as we have used a lower 
dose of streptozotocin (45 mg/kg) for the 
induction of diabetes in rats. 
 Histopathological examination of the pancreas 
showed shrunken islets and degranulation of β-cell 
in the STZ-treated rats. An inadequate mass of 
functional pancreatic β-cell cause hyperglycaemia 
(Bonner-Weir  2000). Endocrine pancreas is 
considered to be a slowly renewed tissue (Finegood 
et al. 1995). Pancreatic β-cell replicates at a rate of 
3% per day and β – cell mass gets doubled in one 
month if the cell death in negligible. Complete 
replacement of β-cell population occurs when the 
replication rate approaches the β – cell death rate. 
The rate of β-cell death is higher in rats treated with 
streptozotocin and this does not match with the 
replication rate. Hence, β-cell population is reduced 
with a subsequent decrease in insulin secretion 
(Hellerstrom et al. 1988).  
Supplementation of fenugreek leaves partially 
retains the damage and increase insulin secretion by 
regeneration of the β-cells and the pancreatic islets 
in streptozotocin induced diabetes in rats.             
Expansion of islets were also noted, which reflects 
the ability of the extract to replicate and increase β-
cell mass. Bonner-Weir (2000) have shown that 
increased β-cell mass secretes more insulin and 
reduce blood glucose levels. This action of the 
fenugreek leaves can be attributed to its antioxidant 
activity by scavenging free radicals and improving 
the antioxidant status (Annida and Stanely Mainzen 
Prince  2004) thereby resulting in islet cell 
expansion. 
Earlier studies have shown that plant extracts 
and antioxidants were beneficial on the STZ-treated 
pancreas. Shanmugasundaram et al. (1990) have 
reported that two water soluble extracts of 
Gymnema sylvestre leaves orally administered to 
STZ-diabetic rats partially regenerated the damaged 
endocrine pancreas, such that the insulin content 
and islet number were increased. Kaneto et al. 
(1999) have reported that N-acetyl L-cysteine 
(NAC) treatment preserved the β-cell function, 
increased β-cell mass, increased insulin content and 
m RNA content in STZ-induced diabetic mice. 
Epicatechin, a phenolic compound increased β-cell 
population in alloxan diabetic rats (Chakravarthy et 
al.  1981). Also probucol – an antioxidant and anti 
– hyperlipidemic agent partially restored β-cell 
function through acting as an antioxidant in STZ- 
induced diabetic APA hamsters (Atsushi et al.  
2003). Aegle  marmelos fruit extract administration 
partially reversed the damage caused by STZ  to the 
endocrine pancreas (Kamalakkannan and Stanely 
Mainzen Prince  2006). 
In summary, the results of our study clearly 
indicate that supplementation of fenugreek leaves 
decrease blood glucose and increase insulin 
secretion by regeneration of the β-cells and the 
pancreatic islets in streptozotocin induced diabetes 
in rats.        
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